Cargando…
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
Pseudomonas aeruginosa is a major opportunistic human pathogen which employs a myriad of virulence factors. In people with cystic fibrosis (CF) P. aeruginosa frequently colonises the lungs and becomes a chronic infection that evolves to become less virulent over time, but often adapts to favour pers...
Autores principales: | Fraser-Pitt, Douglas J., Dolan, Stephen K., Toledo-Aparicio, David, Hunt, Jessica G., Smith, Daniel W., Lacy-Roberts, Niamh, Nupe Hewage, Piumi Sara, Stoyanova, Teodora N., Manson, Erin, McClean, Kevin, Inglis, Neil F., Mercer, Derry K., O’Neil, Deborah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494450/ https://www.ncbi.nlm.nih.gov/pubmed/34631600 http://dx.doi.org/10.3389/fcimb.2021.718213 |
Ejemplares similares
-
Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016) -
Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014) -
Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
por: Devereux, Graham, et al.
Publicado: (2015) -
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2018) -
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
por: Devereux, Graham, et al.
Publicado: (2016)